New Cancer Agent Debuts in Multiple CancersNew Cancer Agent Debuts in Multiple Cancers
The investigational agent is being tested in phase 3 trials in 3 different tumor types: melanoma, renal cell carcinoma, and lung cancer. Medscape Medical News
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Carcinoma | Health | Hematology | Kidney Cancer | Lung Cancer | Melanoma | Renal Cell Carcinoma | Skin Cancer